BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 01-Nov-2015

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2015 at 3.30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2015.

PHARMAID 04-May-2015

(Q3-Unaudited): Net Profit after tax from Jan'15 to March'15 was Tk. 4.77 million with EPS of Tk. 1.53 as against Tk. 4.19 million and Tk. 1.34 respectively for the same period of the previous year. Whereas Net Profit after tax from July'14 to March'15 was Tk. 20.65 million with EPS of Tk. 6.62 as against Tk. 10.82 million and Tk. 3.47 respectively for the same period of the previous year.

PHARMAID 31-Mar-2015

In response to a DSE query dated March 30, 2015, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

PHARMAID 01-Feb-2015

(H/Y Un-audited): Net profit after tax from July'14 to Dec'14 was Tk. 15.88 million with EPS of Tk. 5.09 as against Tk. 6.63 million and Tk. 2.13 respectively for the same period of the previous year. Whereas net profit after tax from Oct14 to Dec14 was Tk. 8.17 million with EPS of Tk. 2.62 as against Tk. 3.89 million and Tk. 1.25 respectively for the same period of the previous year.

PHARMAID 18-Jan-2015

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

PHARMAID 15-Dec-2014

National Credit Ratings Limited (NCR) has announced the rating of the Company as BBB+ in the long term and ST-3 in the short term based on audited financial statements of the Company up to June 30, 2014.

PHARMAID 02-Dec-2014

Normal trading of the shares of the Company will resume on 03.12.2014 after record date.

PHARMAID 01-Dec-2014

Trading of the shares of the Company will remain suspended on record date i.e., 02.12.2014.

PHARMAID 27-Nov-2014

Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 30.11.2014 to 01.12.2014. Trading of the shares of the Company will remain suspended on record date i.e., 02.12.2014.

PHARMAID 16-Nov-2014

(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported net profit after tax of Tk. 7.71 million with EPS of Tk. 2.47 as against Tk. 2.74 million and Tk. 0.88 respectively for the same period of the previous year.

Previous Next page